TNFSF10 and cancer: Nearly 20 years ago, the TNF superfamily member TRAIL was identified and it immediately became apparent that it exhibited many properties of an ideal cancer therapeutic because of its strong apoptosis induction on transformed cancer cells and lack of harmful side effects for the host.